We read with interest the study of Andraweera et al., published recently in Acta Obstetricia et The FTO gene was first identified by a genome-wide association study as an independent genetic risk factor for obesity [3] ; more recently, the polymorphism has also been implicated in other conditions, such as diabetes mellitus, myocardial infarction, renal failure or cancer.
Sir,
We read with interest the study of Andraweera et The FTO gene was first identified by a genome-wide association study as an independent genetic risk factor for obesity [3] ; more recently, the polymorphism has also been implicated in other conditions, such as diabetes mellitus, myocardial infarction, renal failure or cancer.
However, the exact biological role of the FTO gene remains unclear [4] . The gene is involved in demethylation of nucleic acids. As the correct fetal development is based on the DNAmethylation-based programming, in theory the FTO gene is a promising candidate gene for predisposition to spontaneous abortion. The potential role of FTO in fetal development is further supported by the finding that in humans,FTO is highly expressed in placenta and its expression appears to correlate with increased fetal weight and length [5] .
The fact that our study did not find any difference in FTO genotype between spontaneous abortions and healthy adults may be due to at least two reasons. First, the geographical localization and ethnic composition of our study sample differs from that in the study by Andraweera et al. [1] . Second, there was a major difference in the selection of cases between the studies. Our study has focused on analysis of aborted fetal tissues, not on females with experience of pregnancy loss. It is possible that the methylation status and subsequent fetal development depends on the genetic characteristics/FTO variant of females with a history of recurrent pregnancy loss, rather than on characteristics of the fetus. On the other hand, one would expect that even if the main risk factor is maternal genotype it would be detected in studies using fetal DNA (as it reflects the genotype inherited from the mother). Further studies are needed to confirm or refute the putative association between the FTO and recurrent miscarriage.
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